Larson Financial Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.57K | Sell |
538
-13
| -2% | -$231 | ﹤0.01% | 1815 |
|
|
2025
Q1 | $9.82K | Buy |
551
+7
| +1% | +$125 | ﹤0.01% | 1632 |
|
|
2024
Q4 | $16.2K | Buy |
544
+344
| +172% | +$10.2K | ﹤0.01% | 1287 |
|
|
2024
Q3 | $3.13K | Buy |
+200
| New | +$3.13K | ﹤0.01% | 1754 |
|
|
2023
Q4 | – | Sell |
-130
| Closed | -$2.1K | – | 1875 |
|
|
2023
Q3 | $2.1K | Hold |
130
| – | – | ﹤0.01% | 1348 |
|
|
2023
Q2 | $5.4K | Buy |
+130
| New | +$5.4K | ﹤0.01% | 1084 |
|
|
2019
Q1 | – | Sell |
-376
| Closed | -$13K | – | 526 |
|
|
2018
Q4 | $13K | Buy |
+376
| New | +$13K | 0.01% | 201 |
|